Global Oligonucleotide Synthesis Market Pampered by Technological Progress in Synthetic Chemistry and Growing Applications in Therapeutics and Diagnostics

The global oligonucleotide synthesis market is foreseen to be far more successful than it is now with the exponential slide in cost coupled with other influential strands such as the integration of novel paradigms and pronounced refinement of technology. This has helped scientific researchers to balance their DNA skills in such a time when they are lopsided with DNA synthesis performed better than DNA structure and organization dissection.

According to the analysis of Transparency Market Research (TMR), the global oligonucleotide synthesis market could bear a valuation of around US$4.1 bn by 2025, a leap from US$1.6 bn in 2016 at an 11.2% CAGR for the forecast period 2017–2025.

Leading companies such as Thermo Fisher Scientific dealing with the business of oligonucleotide synthesis are predicted to secure a dominant position in the market by ensuring a strong outreach and organization of a diverse product portfolio. Acquisition could be another business move considered by players to expand their presence in the market for oligonucleotide synthesis. For instance, oligonucleotide synthesis specialty reagents supplier, Link Technologies was recently acquired by LGC, a provider of life sciences tools.

How will Technological Advancement Play Part in Growth?

The demand for oligonucleotide synthesis is prognosticated to be bolstered by therapeutics and diagnostics end users necessitating the application of oligonucleotides at a telling rate. Besides this, the development in technology used in the synthetic chemistry sector could set the tone for a treasured growth in the market. Technological evolution in oligonucleotide synthesis is projected to allow the development of pure oligonucleotides and better and longer sequences that could be employed in miscellaneous molecular biology applications.

Various biotechnology and pharmaceutical enterprises are prophesied to work on formulating advanced and novel methods in synthetic chemistry. Synthesized oligonucleotides company, Integrated DNA Technologies, for instance, explores pioneered methodologies to synthesize oligonucleotides of extreme lengths. Oligonucleotides of approximately 200 base length have been developed by the company that could be engaged in the manufacture of mini-genes conducted with mass spectrometry.

How will North America Sustain Dominance despite Drop in Share?

With a growing presence of a range of pharmaceutical companies, the North America region is envisaged to be a top contender in the international oligonucleotide synthesis market. Most of these companies in the region are expected to focus on leveraging oligonucleotides in diverse sectors such as diagnostics, research, and therapeutics. Although the market for oligonucleotide synthesis in North America could slightly lose its share in future, it is envisioned to retain supremacy with an estimated 34.0% share by 2024. Another factor that could give a hand to increase growth in North America is forecasted to be the rising count of genetic disorders and the subsequent need to develop newer, more effective drugs to treat them.

However, in respect of growth rate, the emerging region of Asia Pacific could outpace other regions with a striking CAGR.


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports